GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ABL Diagnostics (XPAR:ABLD) » Definitions » PB Ratio

ABL Diagnostics (XPAR:ABLD) PB Ratio : 7.31 (As of May. 18, 2024)


View and export this data going back to 1989. Start your Free Trial

What is ABL Diagnostics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-18), ABL Diagnostics's share price is €3.04. ABL Diagnostics's Book Value per Share for the quarter that ended in Jun. 2023 was €0.42. Hence, ABL Diagnostics's PB Ratio of today is 7.31.

The historical rank and industry rank for ABL Diagnostics's PB Ratio or its related term are showing as below:

XPAR:ABLD' s PB Ratio Range Over the Past 10 Years
Min: 0.36   Med: 1.03   Max: 34.49
Current: 7.31

During the past 13 years, ABL Diagnostics's highest PB Ratio was 34.49. The lowest was 0.36. And the median was 1.03.

XPAR:ABLD's PB Ratio is ranked worse than
89.9% of 594 companies
in the Healthcare Providers & Services industry
Industry Median: 2.225 vs XPAR:ABLD: 7.31

During the past 12 months, ABL Diagnostics's average Book Value Per Share Growth Rate was -66.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -50.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -34.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -12.80% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of ABL Diagnostics was 8.30% per year. The lowest was -50.90% per year. And the median was 2.10% per year.

Back to Basics: PB Ratio


ABL Diagnostics PB Ratio Historical Data

The historical data trend for ABL Diagnostics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Diagnostics PB Ratio Chart

ABL Diagnostics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.13 1.12 1.25 1.52 34.49

ABL Diagnostics Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.62 1.52 4.99 34.49 20.91

Competitive Comparison of ABL Diagnostics's PB Ratio

For the Health Information Services subindustry, ABL Diagnostics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ABL Diagnostics's PB Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ABL Diagnostics's PB Ratio distribution charts can be found below:

* The bar in red indicates where ABL Diagnostics's PB Ratio falls into.



ABL Diagnostics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

ABL Diagnostics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2023)
=3.04/0.416
=7.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


ABL Diagnostics  (XPAR:ABLD) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


ABL Diagnostics PB Ratio Related Terms

Thank you for viewing the detailed overview of ABL Diagnostics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ABL Diagnostics (XPAR:ABLD) Business Description

Traded in Other Exchanges
N/A
Address
72c, rue de, WOIPPY, Thionville, FRA, 57140
ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.

ABL Diagnostics (XPAR:ABLD) Headlines

No Headlines